A Phase 3 interventional study of Acetylsalicylic Acid (Aspirin, BAYE4465) and Pseudoephedrine in Common Cold, sponsored by Bayer. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-12-05.
Sponsored by Bayer · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Common Cold with a site in United Kingdom — none open to participants now, 1 under way, none of them phase 3. Common Cold · United Kingdom.
Among the 20 studies in Common Cold with a site in United Kingdom, this one has the largest enrollment, is the only one that started in 2009, is one of 4 in phase 3, and was the 3rd registered.
219 studies on the registry are indexed under Common Cold; 23 are open to participants now.
Browse Common Cold studies →None of the 20 studies in Common Cold with a site in United Kingdom is open now. The open studies under Common Cold, anywhere →
Of the 14 Common Cold studies recruiting now, 4 (29%) set no upper age limit and 9 (64%) stop at 75 or younger; 4 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2009.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 833 is above the median of 150 across 184 interventional studies indexed under Common Cold.
Median enrollment 89 across the 20 interventional studies. Of the 17 that completed or were terminated, 7 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 20 have an industry lead sponsor. The 10 most frequent:
Bayer is the lead sponsor of 1,674 studies on the registry; 51 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 132 (62%) have results posted.
Bayer has 5 studies filed under Common Cold — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 20 studies in Common Cold with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to determine the effectiveness of an acetylsalicylic acid (aspirin) pseudoephedrine combination for the treatment of pain and congestion symptoms compared to the effectiveness of the individual components of the medicine and the placebo (dummy treatment that looks like the real thing).The combination product of acetylsalicylic acid / pseudoephedrine is already marketed in several European countries as Aspirin® Complex.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Acetylsalicylic Acid (Aspirin, BAYE4465) · Drug: Pseudoephedrine
Drug: Acetylsalicylic Acid (Aspirin, BAYE4465)
Drug: Pseudoephedrine
Drug: Placebo
2 Sachets of 500 mg Aspirin Complex.
2 Sachets of 30 mg Pseudoephedrine
Matching Placebo
Reduction of nasal congestion and relief of pain
Time frame: 4 hours
Area under the curve for nasal airflow conductance from baseline
Time frame: 1h, 2h, 3h
Sum of subjective nasal congestion intensity differences
Time frame: 1h, 2h, 3h, 4h and 1, 2, 3 days
Total subjective nasal congestion relief
Time frame: 1h, 2h, 3h,4 h and 1, 2, 3 days
Global assessment of nasal congestion
Time frame: 3 days
Global assessment of pain relief
Time frame: 3 days
Sum of pain intensity differences
Time frame: 1h, 2h, 3h, 4h and 1, 2, 3 days
Total pain relief
Time frame: 1, 2, 3 days
Adverse Event collection and physical examination
Time frame: 3 days
The record gives a start of Sep 2009, a primary completion of Mar 2012 and a completion of Mar 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Aspirin · Pseudoephedrine